应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
未开盘 02-20 16:08:38
4.550
-0.040
-0.87%
最高
4.610
最低
4.530
成交量
229.32万
今开
4.610
昨收
4.590
日振幅
1.74%
总市值
285.88亿
流通市值
285.85亿
总股本
62.83亿
成交额
1,045万
换手率
0.04%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 华润医药 02月20日卖空量成交16.65万股,卖空比例为7.26%
市场透视 · 02-20 16:30
每日卖空追踪 | 华润医药 02月20日卖空量成交16.65万股,卖空比例为7.26%
每日卖空追踪 | 华润医药 02月16日卖空量成交4.3万股,卖空比例为9.93%
市场透视 · 02-16
每日卖空追踪 | 华润医药 02月16日卖空量成交4.3万股,卖空比例为9.93%
博雅生物:控股股东华润医药累计增持公司股份6,050,900股
证券之星 · 02-13
博雅生物:控股股东华润医药累计增持公司股份6,050,900股
每日卖空追踪 | 华润医药 02月13日卖空量成交32.45万股,卖空比例为3.5%
市场透视 · 02-13
每日卖空追踪 | 华润医药 02月13日卖空量成交32.45万股,卖空比例为3.5%
华润医药02月13日主力净流出1268.3万元 散户资金买入
市场透视 · 02-13
华润医药02月13日主力净流出1268.3万元 散户资金买入
口服胰岛素上市折戟 华润医药拟出售天麦生物
经济参考网 · 02-12
口服胰岛素上市折戟 华润医药拟出售天麦生物
14.2亿,华润系大动作
赛柏蓝器械 · 02-12
14.2亿,华润系大动作
研发口服胰岛素未获批准,天麦生物被华润医药14亿元甩卖
蓝鲸财经 · 02-11
研发口服胰岛素未获批准,天麦生物被华润医药14亿元甩卖
华润医药集团投资建设健康消费品产业园
美股速递 · 02-10
华润医药集团投资建设健康消费品产业园
华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园
智通财经 · 02-10
华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园
每日卖空追踪 | 华润医药 02月10日卖空量成交97.3万股,卖空比例为7.38%
市场透视 · 02-10
每日卖空追踪 | 华润医药 02月10日卖空量成交97.3万股,卖空比例为7.38%
华润医药02月10日获主力加仓548.2万元
市场透视 · 02-10
华润医药02月10日获主力加仓548.2万元
华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划
美股速递 · 02-09
华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
智通财经 · 02-09
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
华润医药通过上海联合产权交易所公开挂牌处置资产
美股速递 · 02-09
华润医药通过上海联合产权交易所公开挂牌处置资产
博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业
证券之星 · 02-09
博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业
每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%
市场透视 · 02-09
每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%
华润医药02月09日主力净流入585.0万元 散户资金抛售
市场透视 · 02-09
华润医药02月09日主力净流入585.0万元 散户资金抛售
华润医药完善公司治理机制,明确股东大会与董事会权责
金吾财讯 · 02-06
华润医药完善公司治理机制,明确股东大会与董事会权责
昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。
金吾财讯 · 02-06
昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。
加载更多
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.55,"timestamp":1771574918006,"preClose":4.59,"halted":0,"volume":2293180,"delay":0,"changeRate":-0.008714596949891075,"floatShares":6282510461,"shares":6283000000,"eps":0.530245,"marketStatus":"未开盘","change":-0.04,"latestTime":"02-20 16:08:38","open":4.61,"high":4.61,"low":4.53,"amount":10454987,"amplitude":0.017429,"askPrice":4.55,"askSize":10500,"bidPrice":4.54,"bidSize":27000,"shortable":3,"etf":0,"ttmEps":0.488332,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":0,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.59,"dividendRate":0.02968,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.27243604601687527,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"2613188502","title":"每日卖空追踪 | 华润医药 02月20日卖空量成交16.65万股,卖空比例为7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613188502","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613188502?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576233,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月20日,跌0.87%,卖空量成交16.65万股,较上一交易日增加287.21%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163443a4b5e935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163443a4b5e935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2612190434","title":"每日卖空追踪 | 华润医药 02月16日卖空量成交4.3万股,卖空比例为9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612190434","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612190434?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230630,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月16日,跌0.43%,卖空量成交4.3万股,较上一交易日减少96.95%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163415a700dfb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163415a700dfb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2611526881","title":"博雅生物:控股股东华润医药累计增持公司股份6,050,900股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611526881","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611526881?lang=zh_cn&edition=full","pubTime":"2026-02-13 20:51","pubTimestamp":1770987092,"startTime":"0","endTime":"0","summary":"证券之星消息,博雅生物(300294)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:华润入主多少年则博雅跌了多少年,实控人为什么不增持?博雅生物回复:答:您好,感谢您对本公司的关注。公司控股股东华润医药于2024年11月8日-2025年5月7日累计增持公司股份6,050,900股(占公司总股本1.2000%)。截至目前,除上述增持外,公司未收到控股股东关于增持公司股份计划的通知,如有上述事项,公司将及时履行信息披露义务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300035898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","300294","BK0046","BK0197","BK0239","03320","BK1570"],"gpt_icon":0},{"id":"2611165349","title":"每日卖空追踪 | 华润医药 02月13日卖空量成交32.45万股,卖空比例为3.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611165349","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611165349?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971435,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月13日,跌1.28%,卖空量成交32.45万股,较上一交易日减少88.08%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163519a6f6e649&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163519a6f6e649&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2611165371","title":"华润医药02月13日主力净流出1268.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2611165371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611165371?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:15","pubTimestamp":1770970535,"startTime":"0","endTime":"0","summary":"02月13日, 华润医药股价跌1.28%,报收4.61元,成交金额4474.7万元,换手率0.15%,振幅1.71%,量比0.89。华润医药今日主力资金净流出1268.3万元,上一交易日主力净流入538.2万元。该股近5个交易日上涨1.32%,主力资金累计净流入402.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出432.2万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161756a6f6d263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161756a6f6d263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","03320","BK1191"],"gpt_icon":0},{"id":"2610929212","title":"口服胰岛素上市折戟 华润医药拟出售天麦生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929212","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610929212?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:09","pubTimestamp":1770901758,"startTime":"0","endTime":"0","summary":"2月9日,华润医药(03320.HK)在港交所发布公告,其全资附属公司华润医药投资有限公司拟通过上海联合产权交易所公开挂牌,出售所持有的合肥天麦生物科技发展有限公司(简称“天麦生物”)17.87%股权,挂牌底价为14.2亿元。回顾华润医药与天麦生物的合作历程,双方的渊源始于2016年,当时随着国内糖尿病患者数量持续攀升,胰岛素作为核心治疗药物需求旺盛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602123649470565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610043929","title":"14.2亿,华润系大动作","url":"https://stock-news.laohu8.com/highlight/detail?id=2610043929","media":"赛柏蓝器械","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610043929?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:10","pubTimestamp":1770891043,"startTime":"0","endTime":"0","summary":"01华润系拟与天麦生物“分手”17.87%股权拟卖14.2亿元2月9日,华润医药集团发布消息称,华润医药投资有限公司及华润医药投资附属公司拟公开挂牌转让合肥天麦生物科技发展有限公司17.87%股权,挂牌底价为14.2亿元。尽管此次华润医药投资并未清仓所有股份,但华润系退意已决。2025年上半年总收入1318.67亿元,同比微增2.5%;净利润50.54亿元,同比下降8.8%。此外,目前华润系6家上市药企已披露或预告了2025年业绩情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021219253297a5f264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021219253297a5f264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610026932","title":"研发口服胰岛素未获批准,天麦生物被华润医药14亿元甩卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2610026932","media":"蓝鲸财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610026932?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:33","pubTimestamp":1770813181,"startTime":"0","endTime":"0","summary":"以此估算,天麦生物整体估值约80亿元。天眼查信息显示,华润医药投资有限公司对于天麦生物科技的直接持股比例是20%,实缴出资额1.6亿元,为后者的第一大股东及核心股东。除了全球首个申报上市的口服胰岛素获批失败,天麦生物其他产品也入局较晚,二代、三代胰岛素分别在2018年、2024年才获批,在胰岛素集采落地的大背景下,面临较大的竞争压力。业绩方面,2024年以来,华润医药归母净利润持续下滑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770797829577074253","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"1117458768","title":"华润医药集团投资建设健康消费品产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=1117458768","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117458768?lang=zh_cn&edition=full","pubTime":"2026-02-10 18:09","pubTimestamp":1770718182,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司宣布,将投资兴建健康消费品产业园项目。该举措旨在拓展公司在健康消费领域的产业布局,提升产品研发与生产能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610670645","title":"华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=2610670645","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610670645?lang=zh_cn&edition=full","pubTime":"2026-02-10 18:09","pubTimestamp":1770718149,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 公布,公司非全资附属公司东阿阿胶议决投资及建设健康消费品产业园。拟议项目亦符合东阿阿胶健康消费品业务发展的迫切需要。此外,自建厂房有助于构建东阿阿胶健康消费品领域核心优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0188","BK0196","BK0239","BK0175","000423","BK0187","BK1570","BK1191","03320","SG9999014674.SGD","BK0028","BK0010"],"gpt_icon":0},{"id":"2610608265","title":"每日卖空追踪 | 华润医药 02月10日卖空量成交97.3万股,卖空比例为7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610608265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610608265?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712236,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月10日,涨0.21%,卖空量成交97.3万股,较上一交易日减少40.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163520a492bc0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163520a492bc0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610082576","title":"华润医药02月10日获主力加仓548.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610082576","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610082576?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711344,"startTime":"0","endTime":"0","summary":"02月10日, 华润医药股价涨0.21%,报收4.69元,成交金额6185.0万元,换手率0.21%,振幅1.50%,量比1.26。华润医药今日主力资金净流入548.2万元,上一交易日主力净流入585.0万元。该股近5个交易日上涨4.26%,主力资金累计净流入1643.8万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出714.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161929a492a752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210161929a492a752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"1139668716","title":"华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1139668716","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139668716?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:47","pubTimestamp":1770637648,"startTime":"0","endTime":"0","summary":"华润医药旗下关联单位已着手启动一项潜在交易,拟处置其持有的合肥天麦生物科技发展有限公司17.87%的股权。此次股权变动可能涉及重大资产重组,目前相关方案尚在初步筹划阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610321176","title":"华润医药(03320)潜在出售天麦生物科技约17.87 %股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610321176","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610321176?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:47","pubTimestamp":1770637624,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,本公司全资附属公司华润医药投资有限公司(华润医药投资)已启动潜在出售华润医药投资及其附属公司所持有合肥天麦生物科技发展有限公司(天麦生物科技)的约17.87 %股权(潜在出售事项),其将通过上海联合产权交易所进行公开挂牌,挂牌底价约为人民币14.2亿元。于本公告日期,华润医药投资及其附属公司持有天麦生物科技少于30 %股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","03320","159837","BK1191","LABU","BK1570","BK4588"],"gpt_icon":0},{"id":"1143808481","title":"华润医药通过上海联合产权交易所公开挂牌处置资产","url":"https://stock-news.laohu8.com/highlight/detail?id=1143808481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143808481?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:46","pubTimestamp":1770637574,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司(股票代码:03320)宣布,将采用公开挂牌方式,在上海联合产权交易所对其部分资产进行处置。这一举措旨在优化公司资产结构,提升资源配置效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2610164633","title":"博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610164633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610164633?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:18","pubTimestamp":1770628696,"startTime":"0","endTime":"0","summary":"证券之星消息,博雅生物02月09日在投资者关系平台上答复投资者关心的问题。华润集团成为公司实际控制人后,在新浆站申请、资源嫁接、浆站运营等方面给予大力支持。在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业,不断推动行业健康发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900021764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","03320","BK1570","BK1191","BK0197","BK0239","300294"],"gpt_icon":0},{"id":"2610650785","title":"每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610650785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610650785?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625834,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月09日,涨2.63%,卖空量成交110.65万股,较上一交易日减少28.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163938a6e55208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163938a6e55208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2610502786","title":"华润医药02月09日主力净流入585.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610502786?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624939,"startTime":"0","endTime":"0","summary":"02月09日, 华润医药股价涨2.63%,报收4.68元,成交金额8208.4万元,换手率0.28%,振幅1.75%,量比1.79。华润医药今日主力资金净流入585.0万元,上一交易日主力净流出112.4万元。该股近5个交易日上涨5.17%,主力资金累计净流入1097.8万元;近20日主力资金累计净流出713.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162005a6e53a24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162005a6e53a24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2609519565","title":"华润医药完善公司治理机制,明确股东大会与董事会权责","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519565","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519565?lang=zh_cn&edition=full","pubTime":"2026-02-06 23:17","pubTimestamp":1770391050,"startTime":"0","endTime":"0","summary":"公告明确了股东大会的召开与参与程序,包括会议通知、出席与表决方式,以及电子会议的可行性。董事会的职责与权力也得到了详细规定。他们负责公司的日常运营,执行董事会的决策,并由董事会聘任和解聘。华润医药通过此次公告,展示了其对公司治理结构的重视与不断完善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206232622a4853bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206232622a4853bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2609519552","title":"昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519552","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519552?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:05","pubTimestamp":1770383159,"startTime":"0","endTime":"0","summary":")金吾财讯|昆药集团于2026年2月6日公布了其截至2025年12月31日止年度的未经审核初步财务数据。总体来看,昆药集团在2025年的营收与利润均出现了大幅下降,主要受到中成药集中采购进度不及预期、医保费用管控政策持续深化等多重因素的影响。具体而言,昆药集团2025年度实现营业总收入为人民币657,666.41万元,同比下滑21.72%;营业利润为人民币44,850.80万元,同比下滑51.65%;利润总额为人民币47,355.78万元,同比下滑49.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206214255a6dbdfd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206214255a6dbdfd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","03320","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.013},{"period":"1month","weight":0},{"period":"3month","weight":-0.0401},{"period":"6month","weight":-0.0987},{"period":"1year","weight":-0.1356},{"period":"ytd","weight":0.0225}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.01279},{"month":2,"riseRate":0.7,"avgChangeRate":0.045384},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.026504},{"month":4,"riseRate":0.777778,"avgChangeRate":0.043844},{"month":5,"riseRate":0.555556,"avgChangeRate":0.013028},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004789},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.042472},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.002095},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.020729},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.02714},{"month":11,"riseRate":0.4,"avgChangeRate":0.010225},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000929}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}